Headgear Accessory for Exercise-Induced Laryngeal Obstruction Studies

NCT ID: NCT05314478

Last Updated: 2024-11-08

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-24

Study Completion Date

2023-08-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Exercise-induced laryngeal obstruction (EILO) is a condition in which the larynx, or voice box, narrows during high-intensity exercise, and is often mis-diagnosed. A test called a Continuous Laryngoscopy during Exercise (CLE) test can be performed, where a flexible camera is inserted through the nose and positioned at the back of the throat. While the patient exercises, the camera image can be used to identify the presence of EILO.

During the CLE test it is important that the part of the camera that remains outside the body is held securely in position near the forehead so that a clear and stable image is obtained using a headgear to secure the camera to the patient's head.

There are no headgears available on the market, so we have designed and manufactured one called HALOS (Headgear Accessory for Exercise-Induced Laryngeal Obstruction Studies).

This study is to ensure that HALOS is suitable for use, and to check we have understood and minimised the risks associated with the headgear. The headgear can then be used routinely within the Trust, improving the care that offered to patients.

We will recruit 30 male or female participants who need to undergo a CLE test. The study will be conducted at Broadgreen Hospital, Liverpool, UK. Before the CLE test, participants will attend a screening appointment to discuss the procedure. There will be no follow-up appointments.

During the CLE test, the participants will wear the HALOS headgear while exercising, and the clinician will monitor the image from the camera for signs of EILO. After the test, participants will be asked how tolerable the headgear was, and if they have any concerns about any aspect of it. The clinician will also record how clear and stable the camera image was, how easy it was to use, and any concerns about any aspect of it.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Exercise-Induced Laryngeal Obstruction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

The study is an interventional clinical trial involving a single group of 30 participants undergoing a continuous laryngoscopy during exercise test with the HALOS headgear.
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Participants

Participants will be required to attend a single consultation and screening appointment to discuss the investigation procedure, and this will occur at least a week before the Continuous Laryngoscopy during Exercise (CLE) test. Participants will then attend one appointment for the CLE test. There will be no follow up assessments using the headgear.

Group Type EXPERIMENTAL

Continuous laryngoscopy during exercise test using the HALOS headgear

Intervention Type DEVICE

The participant will undergo the CLE test following standard clinical practice.

The order of events of the aspects of the investigation related to the headgear will be:

1. The headgear is prepared for use.
2. The headgear is fitted onto the participant's head.
3. The endoscope is inserted into the participant.
4. The endoscope is fitted onto the headgear.
5. The CLE test is carried out.
6. The endoscope is removed from the headgear.
7. The endoscope is removed from the participant.
8. The headgear is removed from the participant.
9. The headgear is cleaned and stored.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Continuous laryngoscopy during exercise test using the HALOS headgear

The participant will undergo the CLE test following standard clinical practice.

The order of events of the aspects of the investigation related to the headgear will be:

1. The headgear is prepared for use.
2. The headgear is fitted onto the participant's head.
3. The endoscope is inserted into the participant.
4. The endoscope is fitted onto the headgear.
5. The CLE test is carried out.
6. The endoscope is removed from the headgear.
7. The endoscope is removed from the participant.
8. The headgear is removed from the participant.
9. The headgear is cleaned and stored.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participant is willing and able to give informed consent for participation in the study.
* Male, female or non-binary, aged 18 years or above.
* Able (in the Investigators opinion) and willing to comply with all study requirements.
* Able to undergo a CLE test as judged by the clinician, and where a clinical need of the test for the delivery of healthcare has been identified.

Exclusion Criteria

* Pain, sore areas, broken skin at the site of contact with the headgear.
* Devices, e.g. cochlear implants, that impede the use of the headgear.
* Head circumference is less than 50cm or greater than 63cm, reflecting the 3rd centile for females and 97th centile for males, respectively (Bushby, 1992).

* Skull base/facial surgery or fracture within the previous six weeks
* Major or life threatening epistaxis within the previous six weeks
* Trauma to nasal cavity secondary to surgery or injury within the previous six weeks
* Sino-nasal and anterior skull base tumours/surgery
* Nasopharyngeal stenosis
* Craniofacial anomalies
* Hereditary haemorrhagic telangiectasia
* Severe movement disorders and/or severe agitation
* Vasovagal history
* Bleeding risks
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Liverpool University Hospitals NHS Foundation Trust

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tristan Payne

Role: PRINCIPAL_INVESTIGATOR

Liverpool University Hospitals NHS Foundation Trust

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Liverpool University Hospitals Nhs Foundation Trust

Liverpool, Merseyside, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SP0707

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Video Laryngoscope, New Intubation Device
NCT02095470 COMPLETED PHASE2/PHASE3